Brady Corporation Announces Sale of its French First-Aid Company

Brady says the divestiture allows it to focus on specialty identification and intelligent productivity solutions.

Rhea-AI Summary

Brady (NYSE: BRC) sold its French first-aid business, Securimed, to Safe Life International for approximately EUR 53 million.

The sale price is approximately USD 59 million. Securimed supplies and distributes customized first-aid kits, supplies and related healthcare products, including personal protection, diagnosis materials and emergency-response products. Its customers are predominantly administrative and corporate health and safety departments in France. Founded in 1986, Securimed is headquartered in Cappelle-la-Grande, France. Brady acquired the business in 2010.

2 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 0 points

How the balance works

Positive

• Moderate pointCompleted Securimed sale to Safe Life International for approximately EUR 53 million (approximately USD 59 million). 1.5% of market cap
• Minor pointBrady says the divestiture supports its focus on specialty identification and intelligent productivity solutions.

Negative

• None.

Key Figures

Sale consideration: approximately EUR 53 million (approximately USD 59 million)

Sale consideration

approximately EUR 53 million (approximately USD 59 million)

Sale of Securimed to Safe Life

Key Terms

forward-looking statements, goodwill, form 10-k

3 terms

forward-looking statements regulatory

"statements that are not reported financial results or other historic information are “forward-looking statements.”"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

goodwill financial

"potential write-offs of goodwill and other intangible assets"

Goodwill is the extra value a buyer pays for a company above the measurable worth of its buildings, inventory and other tangible items, reflecting things like brand reputation, customer loyalty and expected future profits. Think of paying more for a café because of its famous name and regulars rather than its furniture alone. It matters to investors because changes in goodwill — for example a write-down if expected benefits don’t materialize — can reduce reported earnings and signal that past acquisitions aren’t delivering as hoped.

View in glossary

form 10-k regulatory

"within Item 1A of Part I of the Company’s Form 10-K"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MILWAUKEE, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady”) announced today that it sold its Securimed SAS (“Securimed”) business for approximately EUR 53 million (approximately USD 59 million) to Safe Life International (“Safe Life”).

Securimed is a supplier and distributor of customized first-aid kits, supplies, and related healthcare products including personal protection, diagnosis materials and products for emergency response. Customers include administrative and corporate health and safety departments predominantly located in France. Securimed was founded in 1986 and is headquartered in Cappelle-la-Grande, France.

“Securimed is a well-known French supplier of healthcare and other safety-related products, which has delivered strong results since Brady’s acquisition in 2010. This transaction places Securimed with high-quality ownership in Safe Life, while allowing Brady to continue to focus on its offering of specialty identification and intelligent productivity solutions and driving long-term value for our shareholders,” said Brady’s President and Chief Executive Officer, Vineet Nargolwala.

Brady Corporation (NYSE: BRC) is a global industrial technology company and a leading provider of identification, safety, and productivity solutions that help organizations of all sizes to identify, connect, protect, track, and optimize what matters most. By combining trusted identification technologies with advanced data capture, enterprise mobility, software and workflow solutions, Brady’s comprehensive offerings enable its customers to improve safety, productivity, accuracy, and operational performance across their most critical functions and in the world’s most demanding environments. For more than 110 years, Brady has established trust and demonstrated its commitment to innovation, serving customers across manufacturing, logistics, healthcare, electronics, telecommunications, aerospace, construction, and other key industries, to make their work safer, smarter, and more connected. Headquartered in Milwaukee, Wisconsin, Brady employs approximately 9,300 people worldwide. Brady stock trades on the New York Stock Exchange under the symbol BRC. Learn more at www.bradycorp.com.

In this release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, statements about the success of the acquisition, including anticipated benefits and synergies of the transaction, future opportunities for the combined company, and any other statements regarding the establishment of a new reporting segment for the IPS business, the combined company’s future operations and future financial position, anticipated economic activity, business strategies, targets, future earnings, anticipated growth, market opportunities, debt levels and cash flows, competition and other expectations and estimates for future periods including plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For the Company, uncertainties arise from: the ability of the Company and the IPS business to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally; potential difficulties integrating the IPS business, or the costs of integrating the IPS business exceeding original estimates; failure of the Company to achieve the anticipated benefits and synergies of the transaction identified in this release on the timeline indicated or at all; the establishment of a new reporting segment for the IPS business; increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for the Company’s products; the Company’s ability to compete effectively or to successfully execute our strategy; the Company’s ability to develop technologically advanced products that meet customer demands; the Company’s ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting the Company’s websites, networks, and systems against security breaches; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; risks associated with the loss of key employees; litigation, including product liability claims; global climate change and environmental regulations; foreign currency fluctuations; our indebtedness, financial condition and fulfillment of obligations thereunder; the ability to service our indebtedness; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in the Company’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of the Company’s Form 10-K for the year ended July 31, 2026.

These uncertainties may cause the Company’s actual future results to be materially different than those expressed in its forward-looking statements. The Company does not undertake to update its forward-looking statements except as required by law.

For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Brady sell Securimed for, and who bought it?

Brady sold Securimed to Safe Life International for approximately EUR 53 million (approximately USD 59 million). The sale is completed.